Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2014

New Issue Announcement

15 October 2014 by Justine Bednorz

New Issue Announcement

Categories 2014, ASX Announcements

Rights Issue Prospectus

17 October 201415 October 2014 by Justine Bednorz

Prospectus

Categories 2014, ASX Announcements, Rights Issue

Fully Underwritten Rights Issue

15 October 2014 by Justine Bednorz

Fully Underwritten Rights Issue

Categories 2014, ASX Announcements

Annual Report and Notice of AGM

14 October 2014 by Justine Bednorz

Annual Report and Notice of AGM

Categories 2014, ASX Announcements

Request for Trading Halt

13 October 2014 by Justine Bednorz

Request for Trading Halt

Categories 2014, ASX Announcements

BIT225 Trial Results Show Effective Cure of Hepatits C

10 October 2014 by Justine Bednorz

BIT225 Trial Results Show Effective Cure of Hepatitis C

Categories 2014, ASX Announcements

Year End Accounts and Preliminary Final Report

29 August 2014 by Justine Bednorz

Year End Accounts and Preliminary Final Report

Categories 2014, ASX Announcements

Quarterly Report 30 June 2014

24 July 2014 by Audrey Thomson

Quarterly Report 30 June 2014

Categories 2014, ASX Announcements, Quarterly Reports

BIT225 Reverses HIV-Induced Impairment of the Immune System

23 July 2014 by Audrey Thomson

BIT225 Reverses HIV-Induced Impairment of the Immune System

Categories 2014, ASX Announcements

Response to ASX Compliance Letter

6 June 2014 by Justine Bednorz

Response to ASX Compliance Letter

Categories 2014, ASX Announcements
Older posts
Newer posts
← Previous Page1 Page2 Page3 Page4 Next →
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 12 December 2025        Legal Notices and Privacy
Cleantalk Pixel